Alpine Global Management’s Exact Sciences EXAS Stock Holding History

Alpine Global Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$1.02M	–	298
2025 Q4	$1.02M	Buy	+10,000	New	+$803K	0.22%	67
2022 Q1	–	Sell	-9,456	Closed	-$736K	–	533
2021 Q4	$736K	Buy	+9,456	New	+$835K	0.11%	195
2019 Q2	–	Sell	-6,410	Closed	-$555K	–	76
2019 Q1	$555K	Buy	+6,410	New	+$546K	0.16%	45

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Alpine Global Management's EXAS Position: Q1 2026 in Review

Alpine Global Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,000 shares — an estimated $1.02M sold.

Alpine Global Management first reported a position in EXAS in Q1 2019 and held it in 3 quarters. The position peaked at $1.02M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Alpine Global Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Alpine Global Management sold 10,000 Exact Sciences shares in Q1 2026, an estimated $1.02M.
Alpine Global Management first reported a position in Exact Sciences in Q1 2019 and held it in 3 quarters.
Alpine Global Management's Exact Sciences position peaked at $1.02M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.